Fundraising FoxCentral Texas Angel Network — 2019 Investments
3 investments dated 2019 · listed companies and verified rows first · show all
Savara is a biopharmaceutical company developing treatments for autoimmune pulmonary alveolar proteinosis (autoimmune PAP) and other rare lung diseases.
BiotechHealthtechMedical DevicesAustin, US
Matt Pauls(Chair of the Board of Directors and Chief Executive Officer)inMike Ciesla(Executive Officer)Badrul Chowdhury(Executive Officer)inSantosh J. Vetticaden(Executive Officer)Gregory D. Gorgas(Executive Officer)Patrick Keran(Executive Officer)
Co-investorsBain Capital Life SciencesGreen Park & Golf VenturesKeiretsu ForumMoore Venture PartnersNew Enterprise Associates (NEA)
Endomedix develops polysaccharide-based biomaterials and medical technology, with a pipeline moving from polysaccharide chemistry toward preclinical testing and clinical trials.
BiotechHealthtechMedical DevicesNew MaterialsMontclair, US
Piyush M.(Founder)inWeiliam Chen(Director)James R. Pastena(Director)John M. Abrahams(Director)Richard Russo(President & CEO)Richard Olson(Director)
Co-investorsHouston Angel NetworkKeiretsu ForumSymbiotic VenturesGolden Seeds
BiotechAustin, US
Laura Bosworth(Executive Officer, Director)Rick Schultz(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.